A study by researchers from the United Kingdom’s National Health Service found that COVID-19 vaccines “may trigger” rheumatic inflammatory diseases.
The diseases include arthritis, vasculitis, lupus, and adult-onset Still’s disease.
According to the study, 80% of patients in the study developed rheumatic diseases 11 days after receiving the COVID-19 vaccine.
About 57% of patients received the Pfizer vaccine, almost 25% received the AstraZeneca vaccine, and 12% received the Moderna vaccine.
Over 27% percent of the patients completely recovered from the disease while 50% improved after being treated.
Two individuals died from their symptoms.
“The short time span between COVID-19 vaccine administration and the onset of R-IMIDs suggests the potential possibility of a cause-and-effect relationship,” the authors wrote in the study.
“Vasculitis was the most reported condition, followed by CTDs and inflammatory arthritis,” the study noted.
“Molecular mimicry, which occurs when the body mistakes foreign substances for its own and mounts an immune response, is the leading explanation for the development of these autoimmune diseases,” The Epoch Times reported. “The authors reasoned that vaccine adjuvants like aluminum may be structurally similar to human proteins. Therefore, the body might have mistaken self-tissue while attacking these adjuvants, perceived as foreign invaders.”
